Capricor Therapeutics, Inc. (CAPR)
NASDAQ·Healthcare·Biotechnology
$28.01
+7.52%
Mkt Cap $1.18B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (16 analysts)
$47.75
Range $13.00 – $62.00
Implied Upside
+70.5%
Consensus $47.75 vs current $28.01
NASDAQ·Healthcare·Biotechnology
$28.01
+7.52%
Mkt Cap $1.18B
Buy
5
Hold
0
Sell
0
Price Target (16 analysts)
$47.75
Range $13.00 – $62.00
+70.5%
Consensus $47.75 vs current $28.01